首页|吸入用乙酰半胱氨酸溶液自研药非临床安全性评价

吸入用乙酰半胱氨酸溶液自研药非临床安全性评价

扫码查看
目的 为吸入用乙酰半胱氨酸溶液自研药的临床安全使用提供依据。方法 取 18 只雄性日本大耳白兔,按体质量分层随机化分组法分为阴性对照组(等体积 0。9%氯化钠注射液)、上市品对照组(原研药 0。1 mg/mL)和给药组(自研药 0。1 mg/mL),各 6 只。雾化吸入给药 35 mg/kg,给药体积均为 0。35 mL/kg,各组均给予相应药物,每日上午、下午各 1 次,连续 14 d。记录呼吸道刺激性症状发生及恢复时间。分别于末次给药 24h及 14d后,各组取 3 只兔处死并解剖,肉眼观察刺激反应,采用苏木素-伊红染色,观察病理形态。取 30 只Hartley豚鼠,按体质量分层随机化分组法分为阴性对照组(0。9%氯化钠注射液 0。8mL/d)、阳性对照组(0。9%氯化钠注射液 0。8 mL/d)、上市品对照组[原研药 80 mg/d(0。8mL/d)]及低剂量组[自研药 40 mg/d(0。4mL/d)]和高剂量组[自研药80 mg/d(0。8mL/d)],各 6 只,各组动物隔日致敏(10%卵白蛋白溶液 0。6 mL/d)1 次,共 3 次。分别于末次致敏 14d及 21d后,各组取 3 只豚鼠,按 2 倍致敏剂量进行激发。根据过敏反应发生率和发生程度综合评价主动全身过敏反应发生情况。结果 各组兔的外观、行为、粪便等均正常,给药后无咳嗽等症状;大体解剖均未见明显异常;与阴性对照组和上市品对照组比较,给药组未见药物延迟或蓄积作用。各组豚鼠未出现与给药相关的异常症状,过敏反应均为阴性。结论 吸入用乙酰半胱氨酸溶液自研药对日本大耳白兔无明显呼吸道刺激作用,对豚鼠无明显的全身致敏作用。
Non-Clinical Safety Evaluation of Self-Made Acetylcysteine Solution for Inhalation
Objective To provide a basis for the clinical safe use of self-made Acetylcysteine Solution for Inhalation.Methods Eighteen Japanese male white rabbits were selected and divided into the negative control group(equal volume of 0.9%Sodium Chloride Injection),the marketed drug control group(original-patented drug,0.1 mg/mL),the treatment group(self-made drug,0.1 mg/mL)by the stratified randomization method based on body mass,with six rabbits in each group.The drugs were given by atomizing inhalation at a dosage of 35 mg/kg and a volume of 0.35 mL/kg.Each group was given the corresponding drug once a day in the morning and afternoon for 14 d.The occurrence and recovery time of respiratory irritation symptoms was recorded.After 24 h and 14 d of the last administration,three rabbits in each group were selected for dissection respectively,and the irritation reaction was observed by naked eyes.The hematoxylin-eosin staining was used to observe pathological morphology.Thirty Hartley guinea pigs were selected and divided into the negative control group(0.9%Sodium Chloride Injection,0.8 mL/d),the positive control group(0.9%Sodium Chloride Injection,0.8 mL/d),the marketed drug control group[original-patented drug,80 mg/d(0.8 mL/d)],the low-dose group[self-made drug,40 mg/d(0.4 mL/d)],and the high-dose group[self-made drug,80 mg/d(0.8 mL/d)]by the stratified randomization method based on body mass,with six guinea pigs in each group.Guinea pigs in each group were given drugs(10%ovalbumin solution,0.6 mL/d)once every other day for three times.After 14 d and 21 d of the last administration,three guinea pigs in each group were selected and stimulated at the twice dose of the above administration.The active systemic allergic reaction was comprehensively evaluated based on the incidence and severity of the allergic reactions.Results The appearance,behavior and feces in each group of rabbits were normal,and there was no relevant symptoms such as cough;after gross anatomy,no obvious abnormality was observed;and there was no drug delay or accumulation effect in the treatment group compared with the negative control group and the marketed drug control group.No drug-related abnormal symptom was observed in each group of guinea pigs,and all allergic reactions were negative.Conclusion Self-made Acetylcysteine Solution for Inhalation dose not induce the obvious respiratory irritation in Japanese white rabbits or obvious systemic sensitization in guinea pigs.

Acetylcysteine Solution for Inhalationself-made drugsafety evaluationrespiratory irritation testactive systemic allergic test

刘静欢、孙立杰、杨娴

展开 >

石家庄四药有限公司,河北 石家庄 050000

河北医科大学药学院,河北 石家庄 050000

河北省大容量注射剂工程技术研究中心,河北 石家庄 050000

吸入用乙酰半胱氨酸溶液 自研药 安全性评价 呼吸道刺激性试验 主动全身过敏性试验

河北省创新能力提升计划项目河北省高层次人才资助项目

225A2704DB2022003038

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(6)
  • 15